Reminder—Respond to Key Immunologic Events RFI by March 15

As we described last month, NIAID is seeking community feedback on two broad topics:

1. The utility, feasibility, and potential approaches to establishing a cohort of subjects at risk of developing autoimmune diseases and obtaining longitudinal samples from this cohort to identify immunologic events that drive disease onset in a productive, cost-effective, and minimally invasive manner.
2. The feasibility of, potential approaches to, and impact of studies of autoimmune disease patient cohorts to define immunologic events that drive flares and remissions.

Email your comments to NIAID_AutoimmEvents@nih.gov by March 15, 2021. Take care not to include any proprietary, classified, confidential, or sensitive information.